Rhumbline Advisers ENLIVEN THERAPEUTICS INC Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024
Number of Shares
49,866
Previous 49,627 0.48%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
N/A
239 Added 0.48%
49,866 $0
Q2 2024

Aug 01, 2024
BUY
N/A
11,420 Added 29.89%
49,627 $0
Q1 2024

May 09, 2024
BUY
N/A
864 Added 2.31%
38,207 $0
Q4 2023

Feb 08, 2024
BUY
N/A
2,980 Added 8.67%
37,343 $0
Q3 2023

Nov 09, 2023
SELL
N/A
-433 Reduced 1.24%
34,363 $0
Q2 2023

Aug 08, 2023
BUY
N/A
34,796 New
34,796 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email